NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Mar 4, 2026, 10:35 AM EST
NAVCO Pharmaceuticals Market Cap
NAVCO Pharmaceuticals has a market cap or net worth of CAD 570.7 thousand as of March 5, 2026.
Market Cap
570.70K
Enterprise Value
646.39K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since April 18, 2023, NAVCO Pharmaceuticals's market cap has decreased from 18.16M to 570.70K, a decrease of -96.86%. That is a compound annual growth rate of -69.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 570.70K | - |
| Dec 30, 2025 | 570.70K | -33.33% |
| Dec 17, 2024 | 856.04K | -15.14% |
| Dec 22, 2023 | 1.01M | -94.44% |
| Apr 18, 2023 | 18.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vencanna Ventures | 1.11M |
| Ayurcann Holdings | 973.52K |
| Captor Capital | 906.60K |
| Steep Hill | 889.83K |
| Global Hemp Group | 697.68K |
| Aequus Pharmaceuticals | 663.17K |
| Greenrise Global Brands | 516.55K |
| Optimind Pharma | 515.74K |